Shiseido Co., Ltd.;The General Hospital Corporation
发明人:
Sam W. Lee,Lakshmi Raj,Anna I. Mandinova,Haruhi Iwaki,Yuji Katsuta,Jotaro Nakanishi
申请号：
US14018704
公开号：
US20140186277A1
申请日:
2013.09.05
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The RhoE GTPase pathway has been identified as a target for screening and treatment methods for the prevention and/or reduction of short- and long-term UVB-induced skin damage, e.g., the prevention and/or reduction of UVB-induced wrinkles. The invention thus features screening and treatment methods for prevention or reduction of UVB-induced skin damage, and related compositions, e.g., cosmetic compositions.
